Fingerprint
Dive into the research topics where Tim Rowland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pharmacokinetics of the inactive favipiravir metabolite, favipiravir hydroxide (M1), as a proxy for establishing metabolic activity in patients receiving intravenous favipiravir for treatment of SARS-CoV-2 infection
Challenger, E., Else, L., Dickinson, L., Rowland, T., Wood, W., Hale, C., Lyon, R., Reynolds, H., Chiong, J., Owen, A., FitzGerald, R., Fletcher, T. & Khoo, S., 3 Sept 2025, In: British Journal of Clinical Pharmacology. 91, S1, p. 22 1 p.Research output: Contribution to journal › Meeting Abstract
Open Access -
A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells.
Challenger, E., Dilly-Penchala, S., Hale, C., Fitzgerald, R., Reynolds, H., Chiong, J., Rowland, T., Fletcher, T., Khoo, S. & Else, L., 21 Apr 2024, In: Journal of Pharmaceutical and Biomedical Analysis. 245, p. 116155 116155.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus) -
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Khoo, S. H., FitzGerald, R., Saunders, G., Middleton, C., Ahmad, S., Edwards, C. J., Hadjiyiannakis, D., Walker, L., Lyon, R., Shaw, V., Mozgunov, P., Periselneris, J., Woods, C., Bullock, K., Hale, C., Reynolds, H., Downs, N., Ewings, S., Buadi, A. & Cameron, D. & 30 others, , 1 Feb 2023, In: The Lancet Infectious Diseases. 23, 2, p. 183-195 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile69 Citations (Scopus) -
Therapeutics for treating mpox in humans
Fox, T., Gould, S., Princy, N., Rowland, T., Lutje, V. & Kuehn, R., 14 Mar 2023, In: Cochrane Database of Systematic Reviews. 2023, 3, p. CD015769 CD015769.Research output: Contribution to journal › Review article › peer-review
Open AccessFile41 Citations (Scopus) -
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2
Walker, L. E., FitzGerald, R., Saunders, G., Lyon, R., Fisher, M., Martin, K., Eberhart, I., Woods, C., Ewings, S., Hale, C., Rajoli, R. K. R., Else, L., Dilly-Penchala, S., Amara, A., Lalloo, D., Jacobs, M., Pertinez, H., Hatchard, P., Waugh, R. & Lawrence, M. & 13 others, , 26 Oct 2021, (E-pub ahead of print) In: Clinical Pharmacology and Therapeutics. 111, 3, p. 585-594 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile17 Citations (Scopus)